Antithrombogenic and antiplatelet activity of optho-isobornyl phenol derivative

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 3, 2008, Pages 328-330

  Plotnikov, M B ^a   Smolyakova, V I ^a   Ivanov, I S ^a   Kuchin, A V ^b   Chukicheva, I J ^b   Krasnov, E A ^c  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b INSTITUTE OF CHEMISTRY   (Russian Federation)

^c SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Ischemia; Ortho isobornyl phenol; Sterically hindered phenols; Thrombosis

Indexed keywords

4 METHYL 2,6 DIISOBORNYLPHENOL; ANTITHROMBOCYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL WALL; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; INTRACARDIAC THROMBOSIS; MALE; NONHUMAN; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; WISTAR RAT;

ANIMALS; BORNANES; BRAIN ISCHEMIA; CRESOLS; FIBRINOLYTIC AGENTS; MALE; PENTOXIFYLLINE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; THROMBOSIS;

EID: 50649089374     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0082-x     Document Type: Article

References (11)

1. Z. S. Barkagan and A. P. Momot, Diagnostics and Controlled Therapy of Homeostasis Disorders [in Russian], Moscow (2001).
2. I. S. Ivanov, Urgent Problems of Experimental and Clinical Pharmacology [in Russian], Tomsk (2007), pp 35-37.
3. A. V. Maxsimenko and E. G. Tishchenko, Thitologiya, 41, No. 9, 81-82 (1999).
4. N. N. Petrishchev, S. A. Shestakova, L. N. Dorokhova, and E. V. Mel'nikova, Fiziol. Zh. SSSR, 75, No. 11, 1515-1520 (1989).
5. M. B. Plotnikov, O. E. Vaisova, and N. I. Suslov, Byull. Eksp. Biol. Med., 117, No. 2, 565-567 (1994).
6. O. V. Sirotkina and T. B. Vavilova, Thromboz, Gemostaz, i Reologiya, No. 2, 3-15 (2007).
7. J. Ambrose and M. Weinrauch, Arch. Int. Med., 156, No. 8, 1382-1391 (1996).
8. G. V. R. Born, Nature, 194, No. 4832, 927-929 (1962).
9. J. M. Gibbins, J. Cell Sci., 117, No. 16, 3415-3425 (2004).
10. K. Labuzek, R. Krysiak, B. Okopien, and Z. S. Herman, Pol. J. Pharmacol., 55, No. 4, 523-533 (2003).
11. M. Sakurai, I. Komine, and M. Goto, Jap. Pharmacol. Therapeut. 13, 135-138 (1985).